Brief: Scancell Holdings Says Phase 2 Data Shows Improvement In Progression Free Survival With iSCIB1+
09/12/2025 07:53
Dec 9 (Reuters) - Scancell Holdings PLC SCLP.L: SCANCELL HOLDINGS PLC - PHASE 2 DATA SHOWS IMPROVEMENT IN PROGRESSION FREE SURVIVAL WITH ISCIB1+ IN PATIENTS WITH FIRST LINE ADVANCED MELANOMA SCANCELL HOLDINGS PLC - STRONG PFS CONSISTENT ACROSS KEY SUBGROUPS WITH ISCIB1+ IN UPDATED SCOPE PHASE 2 TRIAL Source text: ID:nRSI7242Ka Further company coverage: SCLP.L ((Reuters.Briefs@thomsonreuters.com;))